Patent · US Active

Compositions and methods for diagnosing and treating cancer

US9376497B2 · kind B2 · utility

10Cited by
53References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2010
Grant dateJun 28, 2016
Priority date
Expiry dateNov 26, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.